Double your impact Match My Donation

Let's spread the word about Immunotherapy! Click to share this page with your community.
Copy Link

Immunotherapy Patient Summit - Live Stream

Our Cancer Research Institute Immunotherapy Patient Summit in New York City on September 15, 2018 will be available globally via live video stream. 

The Live Stream Summit is a free online event that provides a forum for patients, caregivers, and advocates to learn more about how new breakthroughs in immunotherapy are changing standards of care for all cancers with scientific and healthcare experts. A chat box will be available to submit comments and questions for speakers. 

The Live Stream Summit will be held on Saturday, September 15, begin at 10:00am EDT, and conclude at 2:00pm EDT. 

  • 10:00am: Welcome and introduction from Cancer Research Institute staff
  • 10:15am: Basics of immunotherapy presentation by Charles Drake, M.D., Ph.D. (NYP/CUMC)
  • 10:45am: Latest immunotherapy research update panel discussion moderated by Charles Drake, M.D., Ph.D. (NYP/CUMC) with
    • Jedd Wolchok, M.D., Ph.D (MSKCC)
    • Catherine M. Diefenbach, M.D. (NYU Langone)
    • Gulam A. Manji, M.D., Ph.D. (NYP/CUMC)
  • 11:30am: Patient perspective talk by Karen Koehler, leukemia survivor treated with immunotherapy
  • 12:00pm: Live Stream pauses
  • 1:00pm: Demystifying clinical trials presentation by Cancer Research Institute staff
  • 1:15pm: Immunotherapy patient panel
    • Kerry Alvarado (pancreatic cancer)
    • Belur Bhagavan, M.D. (bladder cancer)
    • Gloria Garcia (small cell lung cancer)
    • Adrienne Skinner (metastatic ampullary cancer with Lynch syndrome)
  • 2:00pm: Live Stream ends

Breakout sessions and clinical trial navigator appointments will not be available online. Visit our website for information on individual cancer types or to find a clinical trial.

Follow our Patient Summit series across the United States and across the globe online with the hashtag #CRISummit.

*Immunotherapy results may vary from patient to patient.